[ACRX] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
06-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -2.57%
YoY- -2.19%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 2,924 386 475 608 941 265 613 183.63%
PBT -6,602 -15,925 -14,423 -12,731 -12,409 -13,674 -12,558 -34.88%
Tax 4 843 885 1,212 3 627 355 -94.98%
NP -6,606 -15,925 -14,423 -12,731 -12,412 -13,674 -12,558 -34.86%
Tax Rate - - - - - - - -
Total Cost 9,530 16,311 14,898 13,339 13,353 13,939 13,171 -19.41%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -225.92 -4,125.65 -3,036.42 -2,093.91 -1,319.02 -5,160.00 -2,048.61 -77.03%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -1.64 -3.98 -3.63 -3.20 -3.15 -3.47 -3.56 -40.38%
EPS Diluted -1.64 -3.98 -3.63 -3.20 -3.15 -3.47 -3.56 -40.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.